TXN and cancer: Taken altogether, the results from this and other studies demonstrate that thioredoxin overexpression might represent a signature in cancer, and that over-activated thioredoxin signaling might be a prognostic marker in cancer, and might also serve as potential therapeutic targets in cancer therapy.